The Ebola virus is an often fatal illness that is spread among the human population via direct contact with blood or bodily fluids from an infected individual. The current Ebola outbreak in Western Africa is the largest and most complex epidemic since the virus was first discovered in 1976, according to the World Health Organization. With a fatality rate currently as high as 70%, officials are declaring this outbreak a public health emergency of international concern.

Maria Croyle, a professor in the College of Pharmacy at the University of Texas at Austin, Kristina Jonsson-Schmunk, a graduate student in pharmacy, and colleagues at the university developed a nasal formulation that improved survival of immunized non-human primates from 67 percent (2 out of 3) to 100 percent (3 out of 3) after challenge with 1,000 plaque forming units of Ebola Zaire 150 days after immunization. This is important since only 50 percent of the primates given the vaccine by the standard route (intramuscular injection) survived challenge.

"Ebola causes devastating outbreaks with fatality rates of 25 - 90 percent in Africa and Asia. Although progress has been made in understanding the virus' biology, no licensed vaccines or treatments currently exist. There is a desperate need for a vaccine that not only prevents the continued transmission from person to person, but also aids in controlling future incidences," said Jonsson-Schmunk. "The main advantage of our vaccine platform over the others in clinical testing is the long-lasting protection after a single intranasal dose. This is important since the longevity of other vaccines for Ebola that are currently being evaluated is not fully understood. Moreover, the nasal spray immunization method is more attractive than a needle vaccine given the costs associated with syringe distribution and safety."

The next stage of Dr. Croyle's research is a Phase I clinical trial that tests the effectiveness of their vaccine in human subjects. They will also further explore preliminary data they have collected for administration of the vaccine as a thin film under the tongue in non-human primates.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Shroud of Turin Skeptic Now Says It's Real 'Evidence to... the Resurrection of Jesus'

Teacher Rebuked for Constitution Day Lesson on Free Speech

Governor DeSantis Announces Special Partnership with TPUSA Meant to Protect Club America Chapters in Florida

Don't Miss This: Erika Kirk's Inspiring Speech to Students at the University of Mississippi

Illegal Border Crossings in September Historically Low

Every Shutdown in Last 35 Years Was Ended by a Continuing Resolution, Like the One Dems Keep Rejecting

Prior to Meeting with China's Xi Jinping, President Trump Announced Policy Change in US Nuclear Weapons Testing

'We Have a Deal': President Trump's 'Amazing' Meeting with China's Xi Jinping

US Missionary Abducted by Suspected Jihadists: 'Pray for His Protection'

State Senator to Call on Trump to Fight Christian Persecution

Report: Gavin Newsom's Prostitution Shield Law Creates Sex Market Full of 12, 13-Year-Old Girls in Downtown L.A.

California Universities Demand Trans-Pronoun Usage to Attend Classes

Trump Administration Rejoins Pro-Life Geneva Consensus to Support International Right to Life

Levin: Today's Congress Is an Example of Why FDR Was Given Trade Deal Authority in 1934

There's About to Be a Huge Shake-Up at ICE; And the Left Is Gonna Be Furious

Trump Vows to 'Get It Done' on SNAP Funding amid Dems' Shutdown

'Life-Threatening Damage': Hurricane Melissa Makes Landfall in Cuba after Battering Jamaica

Alveda King Highlights Current Evidence of Revival; 'Now What Are We Gonna Do With It?!'

Federal Judge Strikes Down Controversial Biden HHS Rule Redefining Sex Discrimination to Include 'Gender Identity'

President Trump's HHS Reversing Biden Policy That Funded Abortions for Illegal Immigrant Minors